Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules
Childhood cancer Death Rates Decline, Incidence Stable, NCI Says In Report
In The Courts: Lilly’s Claims Figured In Scripts Written To Coach Sales res, Court Documents Show
NCI Programs: HMO Research Network wins $16 Million Grant for Prevention Studies
Researcher Falsified EMF Data, ORI Says
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - How MD Anderson and Texas Children’s made plans to build a $1 billion pediatric cancer hospital—one of the world’s largest
- In the Headlines: MD Anderson’s Pisters on doing “something gigantic for pediatric cancer”
- The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
- As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater